Rapporto sull’analisi delle dimensioni del mercato e dell’analisi delle quote del siero di sviluppo della linea cellulare | Previsioni 2031

  • Report Code : TIPRE00015863
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 164
Buy Now

Si prevede che il mercato dei sieri per lo sviluppo di linee cellulari raggiungerà 1.467,92 milioni di dollari entro il 2027 rispetto a 915,58 milioni di dollari nel 2019. Si stima che il mercato crescerà con un CAGR del 6,1% dal 2020 al 2027.

I farmaci rigenerativi hanno il potenziale per sostituire o guarire i tessuti, nonché gli organi, e normalizzare i difetti congeniti. Alcune anomalie, malattie e traumi legati all’età danneggiano i tessuti e gli organi. Nell’ultimo decennio di un secolo, l’industria dell’ingegneria tissutale è emersa in modo impressionante e ora si è evoluta nell’area più ampia della medicina rigenerativa, che si concentra sullo sviluppo di terapie cliniche per il mantenimento, la riparazione, la sostituzione e il miglioramento della funzione biologica. , con l'uso dell'ingegneria cellulare. Lo sviluppo della linea cellulare è una parte cruciale e invariabile della medicina rigenerativa. Pertanto, i progressi nella medicina rigenerativa aumentano la domanda di siero utilizzato nello sviluppo di linee cellulari.

Le linee cellulari svolgono un ruolo importante nella sperimentazione e nello sviluppo di farmaci, nello sviluppo di cellule terapia basata e ricerca relativa ai tessuti tumorali, tra le altre applicazioni. I nuovi farmaci sviluppati nelle aziende farmaceutiche vengono testati in modo sicuro ed efficace su cellule staminali differenziate per verificarne il potenziale. Inoltre, i farmaci rigenerativi che utilizzano modelli cellulari hanno il potenziale per aiutare i ricercatori nel trattamento di intervento precoce per malattie degenerative e lesioni traumatiche. Pertanto, l'aumento dell'uso di farmaci rigenerativi spinge il mercato dei sieri per lo sviluppo delle linee cellulari.

Mercati regionali redditizi per i sieri per lo sviluppo delle linee cellulari

< br />

Approfondimenti di mercato

Crescente adozione di farmaci rigenerativi

I farmaci rigenerativi hanno il potenziale per sostituire o guarire i tessuti , così come gli organi, e normalizzano i difetti congeniti. Alcune anomalie, malattie e traumi legati all’età danneggiano i tessuti e gli organi. Nell’ultimo decennio di un secolo, l’industria dell’ingegneria tissutale è emersa in modo impressionante e ora si è evoluta nell’area più ampia della medicina rigenerativa, che si concentra sullo sviluppo di terapie cliniche per il mantenimento, la riparazione, la sostituzione e il miglioramento della funzione biologica. , con l'uso dell'ingegneria cellulare. Lo sviluppo della linea cellulare è una parte cruciale e invariabile della medicina rigenerativa. Pertanto, i progressi nella medicina rigenerativa aumentano la domanda di siero utilizzato nello sviluppo di linee cellulari.


Le linee cellulari sono determinanti nella sperimentazione e nello sviluppo di farmaci, nello sviluppo di terapie cellulari e nella ricerca correlata ai tessuti tumorali, tra le altre applicazioni. I nuovi farmaci sviluppati nelle aziende farmaceutiche vengono testati in modo sicuro ed efficace su cellule staminali differenziate per verificarne il potenziale. Inoltre, i farmaci rigenerativi che utilizzano modelli cellulari hanno il potenziale per aiutare i ricercatori nel trattamento di intervento precoce per malattie degenerative e lesioni traumatiche. Pertanto, l'aumento dell'uso di farmaci rigenerativi spinge il mercato dei sieri per lo sviluppo di linee cellulari.


Approfondimenti sul tipo

In base al tipo, il mercato del siero per lo sviluppo della linea cellulare è segmentato in siero bovino fetale, siero bovino adulto, siero suino, siero di cavallo e altro siero animale. Nel 2019, il segmento del siero fetale bovino rappresentava la quota maggiore del mercato. La crescita di questo segmento è attribuita all'aumento degli esami del sangue, dei test delle urine e di diverse procedure di imaging.

Mercato globale del siero per lo sviluppo della linea cellulare, per tipo– 2019 e 2027


Approfondimenti sull'utente finale

Basato sull'applicazione, lo sviluppo della linea cellulare globale Il mercato del siero è segmentato in ingegneria tissutale e medicine rigenerative, test di tossicità, ricerca, scoperta di farmaci, bioproduzione. Nel 2019, il segmento della bioproduzione deteneva la quota maggiore del mercato; mentre, si prevede che il segmento della scoperta di farmaci registrerà il CAGR più elevato del mercato durante il periodo di previsione.

Approfondimenti strategici

Lanci e approvazioni di prodotti sono le strategie comunemente adottate dalle aziende per espandere la propria presenza globale e i portafogli di prodotti per soddisfare la crescente domanda dei consumatori. Gli attori del mercato del siero per lo sviluppo della linea cellulare adottano la strategia di collaborazioni per ampliare la base di clienti in tutto il mondo, il che consente loro anche di mantenere il proprio marchio a livello globale.

Mercato del siero per lo sviluppo della linea cellulare - Per tipo

  • Siero bovino fetale
  • Siero bovino adulto
  • Siero suino
  • Siero equino
  • Altri sieri animali

Mercato dei sieri per lo sviluppo di linee cellulari: Per applicazione

  • Bioproduzione
  • Scoperta di farmaci
  • Ingegneria tissutale e medicine rigenerative
  • Test di tossicità
  • Ricerca accademica

Mercato dei sieri per lo sviluppo di linee cellulari - per area geografica

  • Nord America
    • Stati Uniti
    • Canada
    • Messico
  • < li>Europa
    • Francia
    • Germania
    • Italia
    • Regno Unito
    • Spagna
    • Resto dell'Europa
  • Asia Pacifico (APAC)
    • Cina
    • India
    • Corea del Sud
    • Giappone
    • Australia
    • Resto dell'Asia Pacifico
  • Medio Oriente e Asia Africa (MEA)
    • Sudafrica
    • Arabia Saudita
    • Emirati Arabi Uniti
    • Resto del Medio Oriente e dell'Africa. Africa
  • America Centrale e Meridionale
    • Brasile
    • Argentina
    • Resto del Sud America

Profili aziendali

  • Lonza
  • Thermo Fisher Scientific Inc.< /li>
  • Sigma-Aldrich Corporation (Merck KGaA)
  • (Cytiva) Danaher
  • PAN Biotech
  • Corning Incorporated
  • Collezione europea di colture cellulari (ECACC)
  • Bovogen Biologicals Pty Ltd.
  • WuXi AppTec
  • Gruppo ATCC (American Type Culture Collection)
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Cell Line Development Serum?

The cell line is established cell culture, wherein the cells multiply in the apt growth medium and space for growth. Different cell lines are made from other cells. The cell line development market growth is mainly attributed to the serum is broadly important as a source of growth and adhesion factors, lipids, hormones, and minerals for cells' culture in basal media. Besides, the serum also regulates cell membrane permeability and serves as a carrier for lipids, enzymes, micronutrients, and trace elements into the cell.

What are the driving factors for the Cell Line Development Serum industry across the globe?

Increasing Adoption of Regenerative Medicines s expected to propel the growth of the Cell Line Development Serum market. Moreover, rising R&D investments and collaborations among by pharmaceutical and biotechnology companies.

What is the average cost of Cell Line Development Serum treatment ?

The price of Cell Line Development Serum treatment is $ 168.80 for for fetal bovine serum and HyClone Cosmic Calf Serum, New Zealand origin cost at $ 256.00 USD. However, the cost profoundly differs based upon the customization

The List of Companies - Cell Line Development Serum Market

  1. Lonza
  2. Thermo Fisher Scientific Inc.,
  3. Sigma-Aldrich Corporation (MERCK KGaA)
  4. Cytiva (Danaher)
  5. PAN Biotech
  6. Corning Incorporated
  7. European Collection of Cell Cultures (ECACC)
  8. Bovogen Biologicals Pty Ltd.
  9. WuXi AppTec
  10. American Type Culture Collection (ATCC)

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports